Skip to main content

August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology

Leukemia, Oncology
Ibrutinib Outperforms Ofatumumab in Patients with Relapsed/Refractory CLL
Caroline Helwick
Read More
Payment Reform Key to Value-Based Cancer Care
Wayne Kuznar
Read More
Page 4 of 4
Results 31 - 32 of 32